• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Nov 1, 2007; 117(11): 3519–3529.
Published online Oct 18, 2007. doi:  10.1172/JCI30727
PMCID: PMC2030454

Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7


Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) by colonizing the gut mucosa and producing Shiga toxins (Stx). The only factor clearly demonstrated to play a role in EHEC adherence to intestinal epithelial cells is intimin, which binds host cell integrins and nucleolin, as well as a receptor (Tir) that it injects into the host cell. Here we report that EHEC O157:H7 produces adhesive type IV pili, which we term hemorrhagic coli pilus (HCP), composed of a 19-kDa pilin subunit (HcpA) that is encoded by the hcpA chromosomal gene. HCP were observed as bundles of fibers greater than 10 μm in length that formed physical bridges between bacteria adhering to human and bovine host cells. Sera of HUS patients, but not healthy individuals, recognized HcpA, suggesting that the pili are produced in vivo during EHEC infections. Inactivation of the hcpA gene in EHEC EDL933 resulted in significantly reduced adherence to cultured human intestinal and bovine renal epithelial cells and to porcine and bovine gut explants. An escN mutant, which is unable to translocate Tir, adhered less than the hcpA mutant, suggesting that adherence mediated by intimin-Tir interactions is a prelude to HCP-mediated adherence. An hcpA and stx1,2 triple mutant and an hcpA mutant had similar levels of adherence to bovine and human epithelial cells while a stx1,2 double mutant had only a minor defect in adherence, indicating that HCP-mediated adherence and cytotoxicity are independent events. Our data establish that EHEC O157:H7 HCP are intestinal colonization factors that are likely to contribute to the pathogenic potential of this food-borne pathogen.


Since its first description in the early 1980s (1), enterohemorrhagic Escherichia coli (EHEC) of O157:H7 and other serotypes have emerged as a significant cause of serious human gastrointestinal disease worldwide (24). EHEC infections can result in diarrhea ranging from mild to bloody and can induce hemorrhagic colitis (2, 5), and some patients with hemorrhagic colitis develop a severe complication known as the hemolytic uremic syndrome (HUS). HUS is defined as a triad of clinical features that includes acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia, which commonly lead to death (6). This deadly infectious disease affects humans of all ages, but the young and old are the most susceptible to developing HUS (7). Adult cattle, other farm animals, and wild animals are common reservoirs of many EHEC serotypes (8, 9). Human infection occurs through acquisition of the bacteria via consumption of contaminated food (ground meat or vegetables), water, unpasteurized fruit juices, and milk (10, 11).

Hallmarks of EHEC pathogenicity are its ability to produce 1 or 2 Shiga toxins (Stx), which are responsible for HUS (6, 12), and to colonize the gut mucosa, which leads to the development of histopathological attaching and effacing (AE) lesions. EHEC strains contain a pathogenicity island called the locus for enterocyte effacement (LEE), which encodes most of the genetic elements required for the production of AE lesions (5). EHEC are a subset of the Shiga-toxigenic E. coli (STEC) pathogroup, which encompasses E. coli strains that produce Stx and that may or not contain the LEE region. Some cases of severe disease, including HUS, are caused by LEE-negative STEC strains (13), indicating that the LEE region is not essential for pathogenesis of HUS and that factors outside the LEE are involved in disease.

Colonization of the intestinal mucosa is central to the establishment of EHEC infection in humans (4). E. coli O157:H7 strains bind in vitro to several cultured cell types (1416) and in vivo to the gastrointestinal tracts of chickens, gnotobiotic piglets, newborn rabbits, and neonatal calves (14, 1719). In adult cattle, the terminal recto-anal junction is thought to be the primary site of colonization of the bovine gastrointestinal tract (20). Despite efforts to identify putative fimbrial adhesins, the only factor clearly demonstrated to play a role in cell adherence of LEE-positive strains is intimin, an outer membrane protein adhesin that mediates intimate bacterial attachment via recognition of its own injected receptor (Tir) or via recognition of host cell integrin or nucleolin (14, 2124). Nonetheless, intimin mutants are still able to colonize host epithelial cells, suggesting that the bacteria produce other yet-unidentified adhesins. Other, less well–characterized surface proteins have been proposed to be associated with adherence properties (13, 15, 16, 25). However, some of these putative adhesins are found only in certain STEC strains, and more studies are required to clarify their role in cell adherence.

The genome of E. coli O157:H7 contains 16 loci encoding genes putatively involved in fimbriae or pili biosynthesis (2628), but it is unknown how many of them are functional in vivo. Several fimbriae have been identified in EHEC strains, including the sorbitol-fermenting EHEC O157 fimbriae plasmid-encoded (SFP) (29), 2 loci-encoding long polar fimbriae (30), curli (31), F9 (a type I pilus homolog) (32), and a type IV pilus (TFP) in LEE-negative non-O157:H7 STEC (33). The role of most of these pili in host colonization is unknown. The long polar fimbriae of EHEC O157:H7 appear to play a role in pig and sheep colonization (34). Intriguingly, EHEC mutants in the F9 pilus showed more adherence to epithelial cells than the wild-type strain (32). Recently, we reported that EHEC strains produce an adhesion appendage called E. coli common pilus or ECP, which is also produced by other pathogenic and nonpathogenic E. coli (35). EHEC and normal flora E. coli unable to produce ECP were hampered in their ability to adhere to cultured epithelial cells. Nevertheless, it remains to be elucidated whether pili play a biologically significant role in EHEC colonization of the intestine of their natural bovine or accidental human hosts.

TFP are important virulence factors in many pathogenic Gram-negative bacteria, as they mediate adherence to eukaryotic cells and host colonization and are associated with other phenomena related to pathogenicity, including bacterial aggregation, biofilm formation, DNA binding and uptake, and twitching motility (3641). So far, TFP have not been observed in AE-producing EHEC O157:H7. In this study, we demonstrate the expression and assembly of TFP in EHEC O157:H7 and provide data showing that these pili are involved in adherence to cultured human colonic epithelial cells and to porcine and bovine intestinal explants and that the pili induce an antibody immune response in HUS patients. These observations contribute to our knowledge of the mechanisms underlying the interaction of EHEC with host cells.


Visualization of pili structures produced by EHEC O157:H7.

For the last 20 years, attempts to reproducibly express and characterize pili produced by EHEC strains have been unsuccessful. Analysis of the EHEC EDL933’s genome sequence reveals 16 loci with potential to encode pili proteins; however, it is still an enigma what role, if any, pili play in host colonization. We were interested in determining whether, in addition to ECP, EHEC O157:H7 could express and produce any additional pili structures when interacting with host cells.

Ultrastructural studies by negative staining and transmission electron microscopy (TEM) were performed to investigate the presence of pili on 3 prototypic, well-characterized EHEC O157:H7 strains (EDL933, 86-24, and 85-170) cultivated at 37°C on bacteriological media such as Luria-Bertani (LB), Mueller-Hinton, CFA agar, or blood agar. No pili were observed on these strains under these growth conditions (Figure (Figure1A1A and data not shown). These observations indicate that the expression of pili depends on the composition of the growth medium and is under a strict regulatory and environmental control. Since EHEC is a commensal of cattle, we decided to use minimal casein (Minca) medium, as this medium was used in the past to successfully induce expression of fimbriae in bovine enterotoxigenic E. coli (ETEC) (42). After growth at 37°C on Minca agar, we were able to see long (>20 μm), thin, rod-like pili (Figure (Figure1,1, B and C) that associated laterally into bundles, morphologically reminiscent of the ETEC Longus TFP (43). Similar to the production of pili in other E. coli pathogroups (43, 44), the degree of production of the novel EHEC pili varied among the 3 EHEC strains tested.

Figure 1
Electron microscopy of EHEC O157:H7 strains.

Biochemical characterization of novel pili.

To determine the nature of these novel structures, EHEC EDL933 growing on Minca agar at 37°C with 5% CO2 atmosphere was harvested and the pili purified by mechanical shearing and differential centrifugation (45). The purified pili (Figure (Figure2A)2A) were dissociated into pilin monomers of 19 kDa in 16% SDS-PAGE gels (Figure (Figure2B).2B). This protein was subjected to mass spectrometry analysis after trypsin digestion. The peptides obtained showed amino acid sequences that corresponded to the predicted protein PpdD, which is encoded by the prepilin peptidase-dependent gene (ppdD) found in the E. coli K-12 genome (46, 47). The PpdD protein possesses features of class A type IV pilins, namely, it has a short leader sequence, an invariable glycine residue preceding the leader peptide cleavage site, and a hydrophobic region, which contains an invariable glutamate-tyrosine pair of amino acids (48). Previous studies reported that laboratory or pathogenic E. coli strains are not able to assemble the PpdD protein into a pilus structure (49). The present report is the first, to our knowledge, to demonstrate that EHEC O157:H7 or any other E. coli are indeed able to assemble the PpdD type IV pilin into polar long bundles of laterally aggregated filaments, a typical morphological feature of TFP. Thus, we are proposing the name hemorrhagic coli pilus (HCP) to describe the TFP produced by EHEC O157:H7 that are composed of the HcpA (PpdD) protein encoded by the hcpA (ppdD) gene. Furthermore, the pilin monomer reacted specifically in immunoblots with a rabbit polyclonal antibody against the cloned E. coli K-12 PpdD fused to maltose/maltodextrin binding protein (Figure (Figure2B).2B). The bundles of HCP protruding from the bacterial cell were labeled by immunogold labeling (Figure (Figure2C)2C) with anti-PpdDK-12 antibodies (herein referred to as anti-HCP), confirming the identity of HCP. No gold particles were seen associated with the bacterial surface, demonstrating the specificity of the reaction.

Figure 2
Purification, biochemical analysis, and reactivity of HCP with sera from HUS patients.

Organization of the putative HCP operon in EHEC O157:H7.

The amino acid sequence of HcpA of EHEC is similar to that of TFP produced by some bacterial pathogens that colonize host tissues, including PilA of Pseudomonas aeruginosa (55%, GenBank accession number AY113185), PilA of Moraxella catarrhalis (61%, GenBank accession number AY647185), and PilE of Neisseria gonorrhoeae (62%, GenBank accession number AF043652). The HcpA of EHEC is highly conserved among the Enterobacteriaceae and shares over 95% identity with PpdD of E. coli K-12 and Shigella species. The biogenesis of TFP generally requires the function of over 16 genes, often organized in multicistronic operons. It is particularly interesting that HCP production in EHEC is apparently driven by the products of fewer genes, namely, hcpA (pilin gene), hofB (usher gene, herein called hcpB), and hofC (chaperone gene, herein called hcpC). These genes are located immediately downstream from hcpA and share similarity to accessory genes pilB and pilC, respectively, involved in the biogenesis of TFP in P. aeruginosa (Supplemental Figure 1; supplemental material available online with this article; doi:10.1172/JCI30727DS1).

Reactivity of HCP with sera from HUS patients.

The presence of antibodies in convalescent patients is a biological marker of the production of an antigen in vivo. We sought to determine whether patients who suffered HUS developed antibodies against HCP. A pool of 5 sera from patients with HUS was reacted with purified HCP by Western blotting (Figure (Figure2B).2B). A pool of normal human sera was used as negative control. The 19-kDa pilin subunit was recognized by the HUS sera but not by normal human sera, strongly suggesting that HCP might be produced in vivo during EHEC infection.

Demonstration of HCP on EHEC adhering to host cells.

We then investigated the presence of pili-like structures on EHEC bacteria adhering onto cultured HT-29 colonic epithelial cells by high-resolution scanning electron microscopy (SEM). We saw that EDL933 attaching to these human intestinal epithelial cells produced wick-like structures (approximately 20-nm wide) protruding from the bacterial surface (Figure (Figure3A).3A). Similar structures were also seen in EHEC adhering to human colonic cell lines (T84 and Caco2), nonintestinal cell lines (HeLa and HEp-2), and bovine kidney (Madin-Darby bovine kidney [MDBK]) epithelial cells (data not shown). These structures appeared to tether bacteria to each other within the bacterial cluster and to mediate direct binding of the bacteria to the mammalian cell membrane (Figure (Figure3B).3B). We hypothesized that these structures could be HCP and so the identity of these structures was investigated by immunofluorescence microscopy (IFM). EDL933-infected HT-29 cells incubated with anti-HCP antibodies revealed the presence of a specific fluorescence profile consistent with the presence of pili (Figure (Figure4A).4A). Similar fluorescent structures were also seen on EHEC incubated with other cell lines (data not shown).

Figure 3
Ultrastructural SEM analysis of EDL933 adhering to HT-29 epithelial cells.
Figure 4
HCP production in EHEC strains.

Disruption of hcpA reduces EHEC adherence to epithelial cells.

To provide genetic evidence regarding the possible role of HCP in EHEC adherence to epithelial cells, we produced an in-frame deletion in the hcpA gene of EHEC O157:H7 strains EDL933 and 85-170 (Stx), generating mutants EDL933ΔhcpA and 85-170ΔhcpA (triple Δstx1,2ΔhcpA mutant), respectively. Flow cytometry, IFM, and Western blotting (of whole bacterial cell extracts) analyses demonstrated the lack of HCP production in these mutants (Figure (Figure44 and Supplemental Figure 2A). No fluorescent structures were seen on the isogenic hcpA mutant with or without pBAD-TOPO vector in the presence of epithelial cells (Figure (Figure4,4, B and E). Infection of HT-29 cells with EDL933ΔhcpA complemented with plasmids pJX12 (carrying hcpA) or pJX22 (carrying hcpABC) caused the appearance of an abundant fluorescent meshwork of large bundles of long filaments protruding from the bacteria and extending throughout the observation fields (Figure (Figure4,4, C and D). These data indicated that overexpression of hcpA alone or together with hcpB and hcpC was sufficient for assembly of HCP but also that the addition of HcpB and HcpC assembly factors in the hcpA mutant was sufficient to increase the amount of HCP produced. The long bundles of pili produced by EDL933ΔhcpA complemented with pJX12 or pJX22 were decorated with anti-HCP antibodies and secondary antibodies conjugated to 30-nm gold particles, as determined by immuno-SEM (Figure (Figure4F).4F). No gold particles were observed in the control with preimmune serum (data not shown). The specificity of the anti-HCP antiserum was further demonstrated with whole-cell extracts of EDL933 (Figure (Figure4I),4I), in which only the reactive HcpA protein was detected.

To judge the significance of the loss of HCP, EDL933ΔhcpA was used to measure adherence to human colonic cells (T84, HT-29, and Caco2), nonintestinal (HEp-2 and HeLa) cell lines, and bovine (MDBK) cultured epithelial cells. The 85-170ΔhcpA strain was tested only for adherence to MDBK and HT-29 cells. For these infection experiments, we propagated all the strains overnight in Minca medium at 37°C in order to activate them for the production of HCP. The light microscopy images of infected, Giemsa-stained cells show obvious impairment of adherence of the hcpA mutant as compared with the wild-type and the complemented strains (Figure (Figure5). 5).

Figure 5
Qualitative comparison of adherence of wild-type EDL933 and derivative mutants to HT-29 cells.

The level of impairment in adherence of EDL933ΔhcpA was determined by counting bacteria adhering to several human colonic cell lines after extensive washing and cell lysis. Depending on the cell line employed, mutation of the hcpA gene resulted in a 3- to 5-fold decrease in adherence relative to EDL933 (P < 0.0001) (Figure (Figure6).6). Complementation of the hcpA mutant with pJX22 increased adherence (P < 0.0001) to a level slightly higher than that seen in the parental strain. The increase in adherence might correlate with the abundant HCP produced by this strain (Figure (Figure4D).4D). The hcpA mutant grew normally in LB broth, ruling out a growth defect as the cause of the reduced adherence. Adherence of EHEC was greatly, although not completely, reduced by the hcpA deletion, indicating that other colonization factors (e.g., intimin-Tir and ECP) contribute to EHEC adherence to different cell lines. We also observed reduction of adherence by EDL933ΔhcpA to other human nonintestinal (HeLa and HEp-2) and bovine (MBDK) cell lines tested (data not shown). Taken together, the data strongly indicate that HCP mediates adherence to various epithelial cell lines, perhaps by recognition of a common surface receptor.

Figure 6
Quantification of bacterial adherence to human intestinal cells.

Adherence to pig and cow intestinal explants.

Intestinal explants obtained from a 3-week-old healthy pig (ileum and colon) and from cow colon were used in quantitative experiments to compare the ability of HCP-producing strains and the hcpA mutant to adhere. In agreement with the results obtained with the tissue culture adherence assays, the hcpA mutant was also impaired in adherence to the animal intestinal tissue in comparison with the HCP-producing strains (Figure (Figure7).7). Taken together, the adherence data strongly suggest that HCP are intestinal colonization factors with affinity for human, bovine, and porcine epithelial cells. We sought to determine whether EHEC would produce HCP while adhering to animal intestinal explants. Thin sections of infected pig tissues were reacted with anti-HCP antibodies by IFM, and we found that HCP are produced by EDL933 during interaction with pig intestinal tissue and not by the hcpA mutant (Figure (Figure8).8). We found that wild-type EDL933, the complemented ΔhcpA (pJX22), and the Stx mutant adhered abundantly to mucus and cellular debris present on the luminal surface of the intestinal mucosa. Fewer bacteria were multifocally adhered to the serosa; observed within the tunica muscularis, submucosa, and denuded villi; and occasionally adhered to sloughed villous epithelium (Figure (Figure9,9, A, C, and E). In contrast, the hcpA, hcpAstx1,2, and escN mutants adhered in small numbers to the intestinal mucosa (Figure (Figure9,9, B, D, and F). Another interesting observation was that pig explants infected with EDL933, EDL933ΔhcpA(pJX22), and EDL933Δstx1,2 lost their normal architecture, as the intestinal lining epithelium was basically destroyed, as compared with mock-infected tissue (Figure (Figure9,9, A, C, E, and G). In contrast, the tissues infected with the hcpA, hcpA,stx1,2, and escN mutants showed less damage (Figure (Figure9,9, B, D, and F). These data would suggest that the presence of and adherence mediated by HCP is important for colonization of the intestinal mucosa and for subsequent tissue damage.

Figure 7
Adherence of EHEC strains to pig and cow intestinal explants.
Figure 8
Detection of HCP on thin sections of infected pig intestinal explants.
Figure 9
Pig ileum infected with EHEC strains, sliced, and stained with H&E.

Relationship between the intimin-Tir interaction, HCP-mediated adherence, and cytotoxicity.

EHEC causes AE lesions via the intimin-Tir interaction, which is strictly dependent on the function of the T3SS. In some pathogenic bacteria such as P. aeruginosa, TFP are not specifically required for contact-dependent T3SS-translocation of exoenzymes (50). In enteropathogenic E. coli (EPEC), initial attachment to host cells is thought to be mediated by TFP, and T3SS is required in the formation of AE lesions (39, 51, 52). Here, we explored the contribution of T3SS (intimin-Tir interaction), HCP, and cytotoxicity on adherence to host cells. We set out to investigate whether HCP-mediated adherence was a prerequisite for intimate attachment to host cells or whether T3SS-dependent adherence led to activation of HCP production. To test this hypothesis, we employed HCP and T3SS mutants in comparative and quantitative adherence assays. In addition, we included double stx1,2 and triple hcpAstx1,2 mutants to determine how Stx might influence the outcome of the interaction of EHEC with host cells. First, we tested the EDL933 hcpA mutant for production of T3-secreted proteins EspA, B, and D and found that this strain was able to produce Esps at the same level as the wild-type strain (Supplemental Figure 3), suggesting that the hcpA mutant remains capable of recruiting actin and inducing the formation of AE lesions. This notion was confirmed by the fluorescent actin-staining assay, which allowed detection of actin condensation in host cells beneath adhering bacteria (data not shown). Second, we found that EDL933 mutated in escN (a T3SS-associated ATPase gene) was significantly reduced in adherence to colonic cell lines (P < 0.0001), even more than the hcpA mutant (Figure (Figure5,5, B and C, and Figure Figure6).6). Last, the mutation in stx1,2 genes in EDL933 had a negative effect in adherence but not as significant as the mutation in escN, hcpA, or hcpAstx1,2 (Figures (Figures55 and and6).6). EHEC strain 85-170, which lacks Stx production, remains capable of adhering to host cells, further indicating that cytotoxicity is not required for HCP-mediated adherence (Supplemental Figure 2). Thus, these results provokingly suggest that T3SS-associated functions and HCP act synergistically to mediate EHEC attachment and colonization. Taken together, these experiments have shed light into the sequence and relevance of adherence events and mechanisms employed by EHEC O157:H7.

Inhibition of adherence with HCP antibodies.

Rabbit antibodies directed against purified HCP were used to test their ability to block adherence of 3 EHEC O157:H7 strains (EDL933, 86-24, and 85-170). A striking dose-dependent inhibition was observed with the 3 strains used but in particular with strains 86-24 and 85-170 (>90% inhibition) (Figure (Figure10).10). The difference observed between the strains is an indication that the inhibition is not due to the presence of anti-O157 antibodies in the serum employed. These observations further support a role for HCP in adherence to host cells.

Figure 10
Inhibition of EHEC adherence by anti-HCP antibodies.


The epidemiological renaissance and clinical significance of EHEC food-borne infections have stimulated increased interest in the understanding of the pathogenic mechanisms of this deadly organism (7). While it is well established that EHEC colonizes the human colonic mucosa and the terminal rectum of bovines (20), it is not clear what role pili play in host colonization. TFP have not been previously observed in EHEC O157:H7. Many functions associated with pathogenicity in Gram-negative bacteria are attributed to TFP, including twitching motility, adherence to host cells, biofilm formation, DNA uptake, phage attachment, cell signaling, and evasion of immune system (37). In this study, we provide compelling evidence that clearly show that EHEC O157:H7 is able to assemble type IV pilin HcpA into long bundles of pili, which we designate HCP. Analogous to the role that TFP play as colonization factors in other pathogenic bacteria, we hypothesized that HCP are colonization factors of EHEC. We found that HCP are involved in adherence of EHEC O157:H7 to human intestinal (colonic) and nonintestinal cell lines, bovine (kidney) epithelial cells, and to pig and cow gut explants. Our observation that hcpA mutants exhibited a significant decreased attachment to cultured epithelial cells (HT-29, T84, Caco2, HEp-2, HeLa, and MDBK) that could be restored to full adherence by complementation with hcpA alone or in association with hcpBC is a strong indication that HCP promote bacterial adherence to host intestinal and nonintestinal epithelial cells. The comparative adherence studies also revealed that additional adherence factors are still present in EHEC, as the hcpA mutants showed some residual adherence to cultured human and bovine epithelial cells. The residual adherence could be attributed to the presence of intimin-Tir and the production of ECP.

It has been suggested that the terminal rectum, rather than the intestine, is the primary colonization site of EHEC O157:H7 in bovines and that components encoded by the LEE4 operon are required for rectal colonization (20). In this context, HCP might play an accessory role in the colonization of the bovine host in association with other LEE- or non-LEE–encoded adhesins. Gnotobiotic pigs have been used as a model to study events of EHEC pathogenesis. In fact, the role of intimin as an adhesin in vivo was demonstrated in a porcine model (21). We employed porcine and bovine intestinal explants to study the role of HCP as a colonization factor in vitro. As predicted, the hcpA mutant was impaired in adherence to animal tissue as compared with HCP-producing strains. Interestingly, we showed that HCP are produced by EDL933 infecting pig intestinal tissue, as thin sections of infected pig explants reacted with anti-HCP antibody by IFM. Considerable tissue damage was observed by the wild type, the Stx mutant, and the EDL933ΔhcpA(pJX22) while the explants incubated with hcpA mutant retained their apparent normal architecture. In all, these data are compelling evidence that support our hypothesis that HCP are intestinal colonization factors.

The intimin-Tir interaction, which is dependent on the presence and function of the T3SS, is crucial for the development of intimate attachment and effacing of the enterocyte membrane, although not enough to mediate attachment in the absence of HCP. In addition to their central role in cytotoxicity and the development of HUS, Stx have been reported to induce the expression of surface-exposed nucleolin on mammalian cells (24), which acts as an alternative receptor for intimin. We explored whether T3SS-dependent or Stx-induced adherence was a requirement or a consequence of the adherence mediated by HCP to cultured epithelial cells. To this aim, we analyzed in comparative and quantitative assays the ability of escN, stx1,2, hcpA, and hcpAstx1,2 mutants to adhere to various human intestinal colonic cell lines. Under our experimental conditions, EHEC strain 85-170, which does not produce Stx, adhered to colonic cells as efficiently as Shiga-toxigenic EDL933. When the stx1,2, and hcpA genes were interrupted in EDL933 and 85-170 was mutated in hcpA, we found that both mutants showed levels of adherence similar to those of the single EDL933 hcpA mutant. These results suggest that HCP-mediated adherence is independent of cytotoxicity and that Stx-mediated adherence does not contribute to the function of HCP. When the intimin-Tir interaction and HCP-mediated adherence were compared, we observed that the level of adherence of the escN mutant (unable to translocate Tir) and the hcpA mutant were 6- to 27-fold and 3- to 5-fold (depending on the cell line employed), respectively, in comparison with the wild-type strain. These results further support that the functional T3SS and the intimin-Tir–mediated adherence are central to EHEC interaction with host cells and strongly suggest that HCP functions as an important accessory colonization factor. The results of the ultrastructural and IFM studies obtained here strongly suggest that HCP contribute to consolidate the formation of infectious units by bridging bacteria. However, we cannot exclude the possibility that HCP also mediate direct contact of the bacteria to a particular receptor, which is apparently widely distributed among intestinal and nonintestinal cells. For P. aeruginosa, the contact-dependent translocation of exoenzymes and cytotoxins via T3SS occurs independently of TFP (50). Whether HCP acts at early or late stages of the colonization process requires further investigation.

Our investigation of the in vitro conditions for pilus production in wild-type EHEC O157:H7 strains, using different growth environments and culture media, revealed that EHEC produces HCP after growth in Minca medium (42) and in contact with host cells. The data would suggest that, like TFP production in other pathogens (53, 54), the production of HCP in EHEC O157:H7 is probably tightly regulated. It is possible that growth of the bacteria in Minca relieves the negative regulation exerted in other growth conditions by an unknown repressor or that signals present in Minca induce the expression of a specific activator. We speculate that the environmental and nutritional signals that trigger HCP production must resemble those found in vivo, perhaps during colonization of the large intestine of animals and humans, and efforts are underway to identify these precise signals.

Earlier studies showed that laboratory or pathogenic E. coli strains were unable to produce HcpA-containing (PpdD-containing) pili, even when expression levels of both hcpA/ppdD and assembly genes (hcpB/hofB and hcpC/hofC) were increased. Production of PpdD pili was only observed in a heterologous host such as P. aeruginosa lacking endogenous TFP (49) or in E. coli producing the pullulanase type II secreton of Klebsiella oxytoca (55). The fact that HCP are produced in EHEC O157:H7 strains suggests the presence of a TFP biogenesis machinery and regulatory genes that are absent or are defective in E. coli K-12 (45, 49). Assembly of TFP requires, depending on the organism, from 16 to 40 biogenesis genes (37). Genetic complementation studies involving the transfer of hcpABC genes on a plasmid expressed from an inducible promoter to the EHEC HCP mutant yielded a strain that was able to hyperproduce HCP. This would suggest that the induction of only these 3 genes is sufficient for HCP production. We cannot rule out that other genes present in the chromosome of EHEC are important for HCP biogenesis. The hcpABC genes are remarkably well conserved in E. coli, Shigella, and several other enterobacterial species, suggesting that under certain environmental conditions, HCP might be produced by these organisms and play an important role in adaptation and survival.

The elucidation of the detailed mechanisms of colonization of human and bovine hosts will be important to further our understanding of EHEC pathogenesis and in the development of strategies to prevent EHEC infections. In this context, HCP should be considered an accessory colonization factor that together with intimin-Tir and ECP contributes to the colonization of the gastrointestinal tract of humans and bovines.


Bacterial strains and culture conditions.

Bacterial strains and plasmids used in this study are listed in Table Table1.1. Bacteria were routinely cultured in LB broth at 37°C with shaking, unless otherwise stated. When required, antibiotics kanamycin (100 μg/ml) and ampicillin (100 μg/ml) were added to the media. Minca minimal medium (1.36 g KH2PO4, 10.1 g Na2HPO4.2H2O, 1 g glucose, 1 g casaminoacids, 10 g MgSO4.7H2O, 1 g MnCl2.4H2O, 0.135 g FeCl3.6H2O, and 0.4 g CaCl2.2H2O per liter adjusted to pH 7.5) (42) was used for production of HCP and for preparing bacterial cultures for comparative adherence assays. Arabinose was used at 100 mM in LB broth to induce l red recombinase production from plasmid pKD46 (56). For induction of the pBAD-TOPO inducible promoter, 0.8% arabinose was added to the medium.

Table 1
E. coli strains and plasmids used

DNA manipulations.

Agarose gel electrophoresis, transformation, PCR, restriction enzyme digestions, ligation, and other routine DNA procedures were carried out as previously described (57).

Construction of EHEC pili mutants.

The l red recombinase system was used to construct hcpA nonpolar deletion mutants of EHEC O157:H7 strains EDL933 and 85-170 (56). G68 and G69 primers, homologous to sequences within the 5′ and 3′ ends of the hcpA gene, were used to replace this gene with a kanamycin-resistance cassette derived from the template plasmid pKD4 (Table (Table1)1) (56). Primers G336 and G337 were used for mutagenesis of stx1,2. Primers flanking the hcpA (G98 and G99) or stx1,2 (G338 y G339) genes as well as primers inside the kanamycin resistance gene (K1 and K2) were used to confirm the required gene replacement by PCR. The resulting hcpA mutants in EDL933 and 85-170 were named EDL933ΔhcpA and 85-170ΔhcpA, respectively. To complement hcpA mutants, hcpA alone or together with the hcpBC genes was amplified from EDL933 using the primers listed in Table Table22 and cloned into the NcoI site and thymidine overhang of pBAD-TOPO. The resulting plasmids (pJX12 and pJX22) were obtained in HB101 and then electroporated into the hcpA mutants to yield EDL933ΔhcpA(pJX12) and EDL933ΔhcpA(pJX22). Expression of genes under araBAD promoter control was induced with 0.8% arabinose.

Table 2
List of primers used


Rabbit antibody against an E. coli K-12 PpdD-GST fusion was used after 4× adsorption with the EDL933 hcpA mutant to remove nonspecific antibodies. This antibody is referred to as anti-HCP in the text. Antisera against EspA, EspB, and EspD were available from previous studies (58, 59). Human sera obtained from HUS patients that gave informed consent and were a kind gift of Phillip Tarr (Washington University, St. Louis, Missouri, USA) to James B. Kaper, and normal human sera were obtained from the collection of the Center for Vaccine Development, University of Maryland.

Electron microscopy and immunogold labeling.

For TEM, a drop (10 μl) of bacterial culture or pili sample was placed on a Formvar carbon–coated grid for 3 minutes, negatively stained with 1% sodium phosphotungstic acid (pH 7.2) for 1 minute, and examined under a Philips transmission electron microscope. For immunogold EM, bacteria were mixed with anti-HCP sera diluted 1:10 in PBS containing 1% (wt/vol) BSA for 1 hour and washed with PBS-BSA. Goat anti-rabbit immunoglobulin labeled with 10-nm gold particles (BB International) diluted 1:10 in PBS-BSA was used to detect antibodies bound to pili and then negatively stained as above (58). For SEM, infected cells were fixed with 2% formalin in PBS, postfixed with 1% osmium tetraoxide, dehydrated by sequential ethanol concentrations, dried to critical point, and coated with a mixture of gold and palladium. Specimens were examined in a high-resolution Leo scanning electron microscope.

Pilus purification.

HCP produced by EDL933 were detached from the bacteria cultivated in 40 plates (150 × 15 mm) of Minca agar supplemented with 0.8% arabinose by vigorous shaking. Pilus purification was monitored by TEM and SDS-PAGE, as previously described (39). In brief, bacteria were separated by centrifugation at 10,000 g for 30 minutes, and the supernatant was centrifuged at 18,000 g for 30 minutes to remove flagella, outer membranes, and bacterial debris. The pili-containing supernatant was centrifuged at 78,000 g for 2 hours and the pellet dissolved in distilled water and then loaded onto a cesium chloride/1% Sarkosyl gradient (density 1.2 g/ml) to obtain relatively pure pili (58). The gradient was centrifuged at 50,000 g for 24 hours at 18°C, after which an opaque thick band was seen in the middle of the gradient. The material in this band was recovered by lateral puncture, dialyzed against distilled water, and observed by TEM.

SDS-PAGE and Western blotting analyses.

Pili preparations from the purification steps and normalized whole-cell lysates were separated by SDS-PAGE on 16% acrylamide gels (60). Western blotting was carried out using anti-HCP antibody at a dilution of 1:2,000 and a horseradish peroxidase conjugate (1:20,000). Blots were developed with HyGLO chemiluminescent HRP antibody detection reagent (Denville Scientific Inc.).

Mass spectrometry.

A protein band of 19 kDa was excised from polyacrylamide gels and subjected to mass spectrometry analysis after digestion with trypsin at the Proteomics Core Facility at the College of Pharmacy, University of Arizona.

Flow cytometry.

Flow cytometry was used to detect the expression of HCP produced by EHEC O157:H7 strains grown overnight at 37°C in Minca media. The cultures were adjusted to an optical density (OD600) of 1.1, and 45-μl aliquots were incubated for 1 hour on ice with 25 μl of anti-HCP using a dilution of 1:1,000. After 3 gentle washes with PBS, the bacteria were suspended in 25 μl of a dilution of goat anti-rabbit IgG (H+L) Alexa Fluor conjugate (Invitrogen). After 1-hour incubation at 4°C, the bacteria were gently washed 3 times with PBS and resuspended in 800-μl final volume of PBS. For the analysis, the bacteria were labeled with 5 μl of a propidium iodide solution (Sigma-Aldrich). Propidium iodide was visualized through a 42-nm band pass centered at 585 nm. These experiments were repeated 3 times in triplicate. The FITC fluorescence emission was collected through a 30-nm band-pass filter centered at 530 nm in which 50,000 events were measured. The samples were analyzed at the ARL Biotechnology/ACCC Cytometry Core Facility at the University of Arizona, by using a FACScan (BD).

Bacterial adherence to epithelial cells.

We employed human polarized intestinal colonic epithelial cells (HT-29, T84, and Caco2) and nonintestinal cells (HeLa and HEp-2) as well as bovine kidney (MDBK) cell lines. These cells were cultivated at 37°C under 5% CO2 atmosphere in polystyrene 24-well plates (CellStar) containing glass coverslips, as previously described (58). For the adherence assay, cell monolayers at 60%–80% confluency were washed and reconstituted with DMEM (Invitrogen). As inoculum, we used 107 bacteria grown overnight in Minca broth at 37°C. The cells were infected from 3 to 6 hours, washed with PBS to remove unbound bacteria, fixed with 2% formalin/PBS for 20 minutes, and stained with Giemsa for 20 minutes. The coverslips were mounted on glass slides to be observed by light microscopy. For quantitative assessment of bacterial adherence (wild type versus mutants) to epithelial cells, cell monolayers were treated with 1 ml of 0.1% Triton X-100 for 5 minutes. Following lysis, bacteria were quantified by plating out 10-fold dilutions of the bacterial suspensions. Quantifications were performed in triplicate on 3 different days, and the results were expressed as adhering CFUs. To evaluate growth fitness of hcpA mutants compared with wild-type strain, overnight cultures were standardized to an OD600 of 1.0 and diluted 1:100 in 100 ml LB in a 250 ml flask. All cultures were incubated at 37°C with shaking (200 rpm). Growth of each bacterial strain was assessed by measuring OD600 every 30 minutes for a total of 8 hours.


Primary anti-HCP antibodies were added to formalin-fixed cells for 1 hour in 10% horse serum followed by the appropriate secondary Alexa Fluor conjugate and then visualized using an Axio Imager 1.0 Zeiss microscope as previously described (58).

Inhibition of adherence with antibodies.

Antibodies against HCP were used to test their ability to block adherence by 3 EHEC O157:H7 strains, namely EDL933, 86-24, and 85-170. Before the 6-hour HT-29 cell adherence assay described above, 10 μl of the bacterial inoculum were incubated for 30 minutes with 1:10, 1:50, and 1:100 dilutions of the anti-HCP and preimmune sera in triplicate. The number of adhering bacteria per cell in each sample was determined by direct observation of Giemsa-stained infected MDBK cells under a light microscope. At least 10 fields per sample were observed, and the average obtained was plotted.

Adherence to pig and cow intestinal explants.

Animal tissues for this work were obtained after approval of animal protocol ID 07-D/I-009-A/H approved by the Institutional Animal Care and Use Committee (IACUC) and the Institutional Biosafety Committee, Iowa State University. Intestinal tissue (ileum and colon) from 3-week-old pigs and bovine colon (a gift from the Meat Science Laboratory, University of Arizona) was obtained as previously described (61). The tissues were rinsed thoroughly with HEPES-Hanks buffer (pH 7.4), cut into 8 × 8 mm squares (0.8 g of weight), and split open with a scalpel, then flushed with HEPES-Hanks buffer (pH 7.4) to remove debris. The tissues were incubated for 6 hours with 10 μl of bacteria grown overnight in Minca broth to induce activation of HCP. We employed EDL933, EDL933ΔhcpA, EDL933ΔhcpA(pJX22), and EDL933ΔhcpA(pBAD-TOPO) strains. After infection, unbound bacteria were removed by washing with HEPES-Hanks buffer, and the attached bacteria were detached by vortexing for 10 minutes with glass beads and then serially diluted and plated on MacConkey sorbitol agar to obtain CFUs. The results shown are the mean of 3 experiments performed in triplicate.


Data corresponding to adherence assays were compared using ANOVA and then the Tukey test. The significance level was 5% in all tests. The SPSS statistical package was used.

Supplementary Material

Supplemental data:


We thank Anthony Pugsley for critical discussion and reading of the manuscript; Phillip Tarr for providing human HUS sera to J.B. Kaper; María Rendón and Alejandra Vázquez for technical assistance; and Partha Samadder for helpful discussions. This work was supported by grant 7015 from the Arizona Biomedical Research Commission (to J.A. Girón); NIH grants AI60211 and AI061020-01 (to J.A. Girón) and DK58957 and AI21657 (to J.B. Kaper); and grants from DGAPA (IN201703-3), CONACyT (42918Q), and HHMI (75301-565101) (to J.L. Puente). J.A. Girón thanks the Arizona Hispanic Center of Excellence for support.


Nonstandard abbreviations used: AE, attaching and effacing; ECP, Escherichia coli common pilus (pili); EHEC, enterohemorrhagic Escherichia coli; HCP, hemorrhagic coli pilus (pili); HUS, hemolytic uremic syndrome; IFM, immunofluorescence microscopy; LB, Luria-Bertani; LEE, locus for enterocyte effacement; MDBK, Madin-Darby bovine kidney; SEM, scanning electron microscopy; STEC, Shiga-toxigenic E. coli; Stx, Shiga toxin(s); TEM, transmission electron microscopy; TFP, type IV pilus (pili).

Conflict of interest: The authors have declared that no conflict of interest exists.

Citation for this article: J. Clin. Invest. 117:3519–3529 (2007). doi:10.1172/JCI30727


1. Riley L.W., et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. . N. Engl. J. Med. 1983;308:681–685. [PubMed]
2. Griffin P.M., et al. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. . Ann. Intern. Med. 1988;109:705–712. [PubMed]
3. Kaper, J.B., Gansheroff, L.J., Wachtel, M.R., and O’Brien, A.D. 1998. Intimin-mediated adherence of Shiga Toxin-producingEscherichia coli and attaching-and-effacing pathogens. InEscherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. J.B. Kaper and A.D. O’Brien, editors. American Society for Microbiology. Washington, DC, USA. 148–156.
4. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. . Nat. Rev. Microbiol. 2004;2:123–140. [PubMed]
5. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. . Clin. Microbiol. Rev. 1998;11:142–201. [PMC free article] [PubMed]
6. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. . Clin. Microbiol. Rev. 1998;11:450–479. [PMC free article] [PubMed]
7. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. . Lancet. 2005;365:1073–1086. [PubMed]
8. Caprioli A., Morabito S., Brugere H., Oswald E. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. . Vet. Res. 2005;36:289–311. [PubMed]
9. Borczyk A.A., Karmali M.A., Lior H., Duncan L.M. Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. . Lancet. 1987;1:98. [PubMed]
10. Cody S.H., et al. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. . Ann. Intern. Med. 1999;130:202–209. [PubMed]
11. Crump J.A., et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. . N. Engl. J. Med. 2002;347:555–560. [PubMed]
12. Karmali M.A., Steele B.T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. . Lancet. 1983;1:619–620. [PubMed]
13. Paton A.W., Srimanote P., Woodrow M.C., Paton J.C. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. . Infect. Immun. 2001;69:6999–7009. [PMC free article] [PubMed]
14. McKee M.L., Melton-Celsa A.R., Moxley R.A., Francis D.H., O’Brien A.D. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. . Infect. Immun. 1995;63:3739–3744. [PMC free article] [PubMed]
15. Tarr P.I., et al. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. . Infect. Immun. 2000;68:1400–1407. [PMC free article] [PubMed]
16. Nicholls L., Grant T.H.R., Robins-Browne R.M. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. . Mol. Microbiol. 2000;35:275–288. [PubMed]
17. Ashkenazi S., May L., LaRocco M., Lopez E.L., Cleary T.G. The effect of postnatal age on the adherence of enterohemorrhagic Escherichia coli to rabbit intestinal cells. . Pediatr. Res. 1991;29:14–19. [PubMed]
18. Dean-Nystrom E.A., Bosworth B.T., Cray W.C., Jr., Moon H.W. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. . Infect. Immun. 1997;65:1842–1848. [PMC free article] [PubMed]
19. Stavric S., Buchanan B., Gleeson T.M. Intestinal colonization of young chicks with Escherichia coli O157:H7 and other verotoxin-producing serotypes. . J. Appl. Bacteriol. 1993;74:557–563. [PubMed]
20. Naylor S.W., et al. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. . Infect. Immun. 2003;71:1505–1512. [PMC free article] [PubMed]
21. Donnenberg M.S., et al. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. . J. Clin. Invest. 1993;92:1418–1424. [PMC free article] [PubMed]
22. Frankel G., et al. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. . J. Biol. Chem. 1996;271:20359–20364. [PubMed]
23. Kenny B., Finlay B.B. Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-gamma1. . Infect. Immun. 1997;65:2528–2536. [PMC free article] [PubMed]
24. Robinson C.M., Sinclair J.F., Smith M.J., O’Brien A.D. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. . Proc. Natl. Acad. Sci. U. S. A. 2006;103:9667–9672. [PMC free article] [PubMed]
25. Torres A.G., Kaper J.B. Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells. . Infect. Immun. 2003;71:4985–4995. [PMC free article] [PubMed]
26. Hayashi T., et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. . DNA Res. 2001;8:11–22. [PubMed]
27. Perna N.T., et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. . Nature. 2001;409:529–533. [PubMed]
28. Low A.S., et al. Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. . Environ. Microbiol. 2006;8:1033–1047. [PubMed]
29. Brunder W., Khan A.S., Hacker J., Karch H. Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-). . Infect. Immun. 2001;69:4447–4457. [PMC free article] [PubMed]
30. Torres A.G., et al. Identification and characterization of lpfABCC’DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. . Infect. Immun. 2002;70:5416–5427. [PMC free article] [PubMed]
31. Kim S.H., Kim Y.H. Escherichia coli O157:H7 adherence to HEp-2 cells is implicated with curli expression and outer membrane integrity. . J. Vet. Sci. 2004;5:119–124. [PubMed]
32. Low A.S., et al. Cloning, expression, and characterization of fimbrial operon F9 from enterohemorrhagic Escherichia coli O157:H7. . Infect. Immun. 2006;74:2233–2244. [PMC free article] [PubMed]
33. Srimanote P., Paton A.W., Paton J.C. Characterization of a novel type IV pilus locus encoded on the large plasmid of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. . Infect. Immun. 2002;70:3094–3100. [PMC free article] [PubMed]
34. Jordan D.M., et al. Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo. . Infect. Immun. 2004;72:6168–6171. [PMC free article] [PubMed]
35. Rendon M.A., et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. . Proc. Natl. Acad. Sci. U. S. A. 2007;104:10637–10642. [PMC free article] [PubMed]
36. Craig L., Pique M.E., Tainer J.A. Type IV pilus structure and bacterial pathogenicity. Nat. Rev. Microbiol. 2004;2:363–378. [PubMed]
37. Mattick J.S. Type IV pili and twitching motility. Annu. Rev. Microbiol. 2002;56:289–314. [PubMed]
38. Winther-Larsen H.C., et al. Neisseria gonorrhoeae PilV, a type IV pilus-associated protein essential to human epithelial cell adherence. . Proc. Natl. Acad. Sci. U. S. A. 2001;98:15276–15281. [PMC free article] [PubMed]
39. Giron J.A., Ho A.S., Schoolnik G.K. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. . Science. 1991;254:710–713. [PubMed]
40. Taylor R.K., Miller V.L., Furlong D.B., Mekalanos J.J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. . Proc. Natl. Acad. Sci. U. S. A. 1987;84:2833–2837. [PMC free article] [PubMed]
41. Paranjpye R.N., Strom M.S. A Vibrio vulnificus type IV pilin contributes to biofilm formation, adherence to epithelial cells, and virulence. . Infect. Immun. 2005;73:1411–1422. [PMC free article] [PubMed]
42. Guinee P.A., Jansen W.H., Agterberg C.M. Detection of the K99 antigen by means of agglutination and immunoelectrophoresis in Escherichia coli isolates from calves and its correlation with entertoxigenicity. . Infect. Immun. 1976;13:1369–1377. [PMC free article] [PubMed]
43. Giron J.A., Levine M.M., Kaper J.B. Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli. . Mol. Microbiol. 1994;12:71–82. [PubMed]
44. Gismero-Ordonez J., Dall’Agnol M., Trabulsi L.R., Giron J.A. Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes. . J. Clin. Microbiol. 2002;40:2291–2296. [PMC free article] [PubMed]
45. de Oliveira-Garcia D., et al. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg. Infect. Dis. 2002;8:918–923. [PMC free article] [PubMed]
46. Blattner F.R., et al. The complete genome sequence of Escherichia coli K-12. . Science. 1997;277:1453–1474. [PubMed]
47. Francetic O., Lory S., Pugsley A.P. A second prepilin peptidase gene in Escherichia coli K-12. . Mol. Microbiol. 1998;27:763–775. [PubMed]
48. Strom M.S., Lory S. Structure-function and biogenesis of the type IV pili. Annu. Rev. Microbiol. 1993;47:565–596. [PubMed]
49. Sauvonnet N., Gounon P., Pugsley A.P. PpdD type IV pilin of Escherichia coli K-12 can be assembled into pili in Pseudomonas aeruginosa. . J. Bacteriol. 2000;182:848–854. [PMC free article] [PubMed]
50. Sundin C., Wolfgang M.C., Lory S., Forsberg A., Frithz-Lindsten E. Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa. Microb. Pathog. 2002;33:265–277. [PubMed]
51. Nougayrede J.P., Donnenberg M.S. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. . Cell Microbiol. 2004;6:1097–1111. [PubMed]
52. Hicks S., Frankel G., Kaper J.B., Dougan G., Phillips A.D. Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. . Infect. Immun. 1998;66:1570–1578. [PMC free article] [PubMed]
53. Puente J.L., Bieber D., Ramer S.W., Murray W., Schoolnik G.K. The bundle-forming pili of enteropathogenic Escherichia coli: transcriptional regulation by environmental signals. . Mol. Microbiol. 1996;20:87–100. [PubMed]
54. Edwards R.A., Puente J.L. Fimbrial expression in enteric bacteria: a critical step in intestinal pathogenesis. Trends Microbiol. 1998;6:282–287. [PubMed]
55. Sauvonnet N., Vignon G., Pugsley A.P., Gounon P. Pilus formation and protein secretion by the same machinery in Escherichia coli. . EMBO J. 2000;19:2221–2228. [PMC free article] [PubMed]
56. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. . Proc. Natl. Acad. Sci. U. S. A. 2000;97:6640–6645. [PMC free article] [PubMed]
57. Sambrook, J., and Russell, D.W. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 854 pp.
58. Giron J.A., Torres A.G., Freer E., Kaper J.B. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. . Mol. Microbiol. 2002;44:361–379. [PubMed]
59. Parissi-Crivelli A., Parissi-Crivelli J.M., Giron J.A. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. . J. Clin. Microbiol. 2000;38:2696–2700. [PMC free article] [PubMed]
60. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. [PubMed]
61. Giron J.A., Ho A.S., Schoolnik G.K. Characterization of fimbriae produced by enteropathogenic Escherichia coli. . J. Bacteriol. 1993;175:7391–7403. [PMC free article] [PubMed]
62. Jarvis K.G., Kaper J.B. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. . Infect. Immun. 1996;64:4826–4829. [PMC free article] [PubMed]
63. Tzipori S., et al. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. . Infect. Immun. 1987;55:3117–3125. [PMC free article] [PubMed]
64. Roulland-Dussoix D., Boyer H.W. The Escherichia coli B restriction endonuclease. . Biochim. Biophys. Acta. 1969;195:219–229. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...